XML 60 R38.htm IDEA: XBRL DOCUMENT v3.22.4
TRANSITION PERIOD COMPARATIVE DATA (Tables)
12 Months Ended
Dec. 31, 2022
TRANSITION PERIOD COMPARATIVE DATA  
Schedule of certain comparative financial information

The following table presents certain comparative financial information for the year ended December 31, 2022 and 2021, respectfully (amounts in thousands, except share data).

Years Ended

December 31,

December 31,

2021

2022

(unaudited)

Revenue

$

603,206

$

653,568

Costs and expenses

Cost of sales (excludes depreciation, depletion and amortization)

94,642

98,467

General and administrative

34,612

29,306

Production taxes

7,021

8,399

Depreciation, depletion and amortization

178,935

189,009

Impairment of royalty interests

4,287

Total costs and expenses

319,497

325,181

Operating income

283,709

328,387

Fair value changes in equity securities

(1,503)

2,510

Interest and other income

7,832

3,019

Interest and other expense

(17,170)

(5,753)

Income before income taxes

272,868

328,163

Income tax expense

(32,926)

(53,223)

Net income and comprehensive income

239,942

274,940

Net (income) loss and comprehensive (income) loss attributable to non-controlling interests

(960)

(898)

Net income and comprehensive income attributable to Royal Gold common stockholders

$

238,982

$

274,042

Basic earnings per share

$

3.64

$

4.17

Basic weighted average shares outstanding

65,576,995

65,552,586

Diluted earnings per share

$

3.63

$

4.17

Diluted weighted average shares outstanding

65,661,748

65,624,007

Cash dividends declared per common share

$

1.425

$

1.25

Years Ended

December 31, 

December 31, 

2021

    

2022

    

(unaudited)

Cash flows from operating activities:

Net income and comprehensive income

$

239,942

$

274,940

Adjustments to reconcile net income and comprehensive income to net cash provided by operating activities:

Depreciation, depletion and amortization

178,935

189,009

Non-cash employee stock compensation expense

8,411

6,056

Fair value changes in equity securities

1,503

(2,510)

Deferred tax (benefit) expense

(19,836)

11,371

Impairment of royalty interests

4,287

Other

979

1,663

Changes in assets and liabilities:

Royalty receivables

4,683

(9,771)

Stream inventory

(1,049)

2,292

Income tax receivable

1,849

4,023

Prepaid expenses and other assets

(3,908)

(1,956)

Accounts payable

211

3,862

Income tax payable

(3,005)

(4,248)

Uncertain tax positions

(13,268)

Other liabilities

4,343

406

Net cash provided by operating activities

$

417,345

$

461,869

Cash flows from investing activities:

Acquisition of stream and royalty interests

(922,155)

(400,381)

Khoemacau subordinated debt facility

(25,000)

Proceeds from sale of equity securities

8,651

Other

(721)

(241)

Net cash used in by investing activities

$

(922,876)

$

(416,971)

Cash flows from financing activities:

Repayment of debt

(125,000)

(300,000)

Borrowings from revolving credit facility

700,000

100,000

Net payments from issuance of common stock

(1,447)

(971)

Common stock dividends

(91,925)

(78,738)

Other

(1,062)

(3,497)

Net cash provided by (used in) financing activities

$

480,566

$

(283,206)

Net decrease in cash and equivalents

(24,965)

(238,308)

Cash and equivalents at beginning of period

143,551

381,859

Cash and equivalents at end of period

$

118,586

$

143,551